Germany’s Stada Wants Drug Firms In Russia
This article was originally published in PharmAsia News
Executive Summary
Russian drug makers have been targeted for acquisitions by Germany’s Stada, a maker of generics seeking to expand as its market at home weakens, but so far with no success.